Trials / Completed
CompletedNCT05339243
Evaluating the Safety and Efficacy of the Probiotic Bifidobacterium Longum ES1 and the Post Biotic Heat-treated Bifidobacterium Longum ES1 (HT-ES1) on IBS Symptom Severity in Patients With Diarrhoea Predominant Irritable Bowel Syndrome
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- Vedic Lifesciences Pvt. Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Randomized controlled clinical study has been proposed to evaluate the safety and efficacy of ES1 probiotic strain and heat-treated ES1 postbiotic strain in individuals suffering from IBS-D.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | ES 1 | Two capsules orally once daily after breakfast for 84 days |
| OTHER | HT ES1 | Two capsules orally once daily after breakfast for 84 days |
| OTHER | Placebo | Two capsules orally once daily after breakfast for 84 days |
Timeline
- Start date
- 2022-04-21
- Primary completion
- 2023-01-13
- Completion
- 2023-01-13
- First posted
- 2022-04-21
- Last updated
- 2023-09-08
Locations
8 sites across 1 country: India
Source: ClinicalTrials.gov record NCT05339243. Inclusion in this directory is not an endorsement.